Article Type

1 - 12 of 12 Results       Clear All

Cellular Clean Energy: Can Mitochondria Make More Energy Without Collateral Damage?

Gladstone staff scientist Neal Bennett and investigator Ken Nakamura working in the lab
Article January 11, 2024

Cellular Clean Energy: Can Mitochondria Make More Energy Without Collateral Damage?

New research from Gladstone may help in the development of new therapies that target the problem of cellular energy failure—a hallmark of Parkinson’s, Alzheimer’s, and aging in general

News Release Research (Publication) Alzheimer’s Disease Parkinson’s Disease Neurological Disease Nakamura Lab CRISPR/Gene Editing

Next Wave of Bay Area Neuroscience Companies: What Are They Doing Now?

Gladstone in the News October 2, 2020

Next Wave of Bay Area Neuroscience Companies: What Are They Doing Now?

San Francisco Business Times—Gabaeron, founded by Gladstone President Emeritus Bob Mahley, MD, PhD, and Therini Bio (formerly Medared), founded upon work by Senior Investigator Katarina Akassoglou, PhD, are among Bay Area biotech companies focusing on neurological diseases that collectively raised more than $3 billion from venture capital firms and the public capital markets in 2020.

Gladstone Experts Parkinson’s Disease Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab Mahley Lab

Loss of Cellular Energy Leads to Neuronal Dysfunction in a Model of Neurodegenerative Disease

Ken Nakamura
Article September 13, 2015

Loss of Cellular Energy Leads to Neuronal Dysfunction in a Model of Neurodegenerative Disease

A new study from the Gladstone Institutes shows for the first time that impairments in mitochondria—the brain’s cellular power plants—can deplete cellular energy levels and cause neuronal dysfunction in a model of neurodegenerative disease.

Parkinson’s Disease Neurological Disease Nakamura Lab Basic Science Metabolism

More News

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media